CERO (CERo Therapeutics Holdings) Cash from Discontinued Operating Activities : $0.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is CERo Therapeutics Holdings Cash from Discontinued Operating Activities?

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

CERo Therapeutics Holdings's Cash from Discontinued Operating Activities for the three months ended in Mar. 2025 was $0.00 Mil. It means CERo Therapeutics Holdings received $0.00 Mil from discontinued investing activities. CERo Therapeutics Holdings's Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Mar. 2025 was $0.00 Mil.

CERo Therapeutics Holdings Cash from Discontinued Operating Activities Historical Data

The historical data trend for CERo Therapeutics Holdings's Cash from Discontinued Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CERo Therapeutics Holdings Cash from Discontinued Operating Activities Chart

CERo Therapeutics Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Cash from Discontinued Operating Activities

CERo Therapeutics Holdings Quarterly Data
	Dec21	Mar22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Cash from Discontinued Operating Activities	Get a 7-Day Free Trial							-	-	-	-	-

CERo Therapeutics Holdings Cash from Discontinued Operating Activities Calculation

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

CERo Therapeutics Holdings Cash from Discontinued Operating Activities Related Terms

Thank you for viewing the detailed overview of CERo Therapeutics Holdings's Cash from Discontinued Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

CERo Therapeutics Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Cash from Discontinued Operating Activities

Comparable Companies

Traded in Other Exchanges

N/A

Address

201 Haskings Way, Suite 230, South San Francisco, CA, USA, 94080

Website

https://www.cero.bio

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.